Foundation Medicine Inc is a commercial-stage company. The Company is engaged in changing the way patients with cancer are treated. It delivers genomic information about cancer to its customers.


Updates from The Motley Fool

Latest updates on Foundation Medicine from Fool.com.
Is the IPO Market Overheating?

After Facebook's IPO, investors cooled to initial public offerings. But recent hot issues from Fi...



Stock Performance

View Interactive FMI Charts
Sponsored by

Key Data Points

Primary metrics and data points about Foundation Medicine .
Current Price: $101.95
Prev Close: $106.50
Open: $105.45
Bid: $100.00
Ask: $103.00
Day's Range: $99.65 - $105.50
52wk Range: $31.70 - $109.30
Volume: 548,243
Avg Vol 327,103
Market Cap: $4B
P/E (ttm): -25.30
EPS (ttm): ($4.21)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Foundation Medicine .
CAPS Rating 5 out of 5
 
65 Outperform
2 Underperform
CAPS All Stars
 
23 Outperform
1 Underperform

How do you think Foundation Medicine will perform against the market?



You pick for Foundation Medicine is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Troy Cox, CEO

81% Approve

Based on 12 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Foundation Medicine .

Foundation Medicine Inc is a commercial-stage company. The Company is engaged in changing the way patients with cancer are treated. It delivers genomic information about cancer to its customers.

  • Exchange: NASDAQ